The company produces technologies to address regenerative, curative and preventable conditions and diseases with several patent-pending applications. The company developed the cGTP cellular processing facility in New York City designed to be fully integrated into an ambulatory surgery center.
More Articles on Surgery Centers:
6 Reasons ASC Joint Ventures Fail
5 Key Technology Considerations for ASCs
How ASCs Should Prepare for ACOs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
